AI assistant
Whitehawk Therapeutics, Inc. — Director's Dealing 2025
Apr 3, 2025
34276_dirs_2025-04-03_cc28c6ba-9b51-4c1f-aa86-32048cfcb1d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Whitehawk Therapeutics, Inc. (WHWK)
CIK: 0001422142
Period of Report: 2025-04-01
Reporting Person: Lennon David James (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-01 | Stock Option (right to buy) | $1.70 | A | 775828 | Acquired | 2035-04-01 | Common Stock (775828) | Direct |
| 2025-04-01 | Restricted Stock Units | $ | A | 775828 | Acquired | Common Stock (775828) | Direct |
Footnotes
F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2025.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
F3: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2025.